These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34173979)

  • 1. Molecular and MALDI-ToF MS differentiation and antifungal susceptibility of prevalent clinical Fusarium species in China.
    Song Y; Liu X; Yang Z; Meng X; Xue R; Yu J; Al-Hatmi AMS; de Hoog GS; Li R
    Mycoses; 2021 Oct; 64(10):1261-1271. PubMed ID: 34173979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of molecular and MALDI-TOF MS identification and antifungal susceptibility of clinical
    Guo P; Chen J; Tan Y; Xia L; Zhang W; Li X; Jiang Y; Li R; Chen C; Liao K; Peng Y
    Front Microbiol; 2022; 13():992582. PubMed ID: 36386677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method.
    Espinel-Ingroff A; Colombo AL; Cordoba S; Dufresne PJ; Fuller J; Ghannoum M; Gonzalez GM; Guarro J; Kidd SE; Meis JF; Melhem TM; Pelaez T; Pfaller MA; Szeszs MW; Takahaschi JP; Tortorano AM; Wiederhold NP; Turnidge J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1079-84. PubMed ID: 26643334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex.
    Homa M; Shobana CS; Singh YR; Manikandan P; Selvam KP; Kredics L; Narendran V; Vágvölgyi C; Galgóczy L
    Mycoses; 2013 Sep; 56(5):501-11. PubMed ID: 23437826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular identification and in vitro susceptibility of Fusarium from fungal keratitis in central China].
    Sun S; Lyu Q; Han L; Ma Q; Hu H; He S; Tao S; Zhang J; Zhang H; Wang L
    Zhonghua Yan Ke Za Zhi; 2015 Sep; 51(9):660-7. PubMed ID: 26693650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.
    Tortorano AM; Prigitano A; Esposto MC; Arsic Arsenijevic V; Kolarovic J; Ivanovic D; Paripovic L; Klingspor L; Nordøy I; Hamal P; Arikan Akdagli S; Ossi C; Grancini A; Cavanna C; Lo Cascio G; Scarparo C; Candoni A; Caira M; Drogari Apiranthitou M;
    Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1623-30. PubMed ID: 24791951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India.
    Tupaki-Sreepurna A; Thanneru V; Natarajan S; Sharma S; Gopi A; Sundaram M; Kindo AJ
    Mycopathologia; 2018 Jun; 183(3):529-540. PubMed ID: 29445920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luliconazole, a highly effective imidazole, against Fusarium species complexes.
    Gharaghani M; Hivary S; Taghipour S; Zarei-Mahmoudabadi A
    Med Microbiol Immunol; 2020 Oct; 209(5):603-612. PubMed ID: 32253502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Characterization and Antifungal Susceptibility of Clinical
    Herkert PF; Al-Hatmi AMS; de Oliveira Salvador GL; Muro MD; Pinheiro RL; Nucci M; Queiroz-Telles F; de Hoog GS; Meis JF
    Front Microbiol; 2019; 10():737. PubMed ID: 31024507
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.
    Taj-Aldeen SJ; Kolecka A; Boesten R; Alolaqi A; Almaslamani M; Chandra P; Meis JF; Boekhout T
    Infection; 2014 Apr; 42(2):393-404. PubMed ID: 24352810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
    Gupta C; Jongman M; Das S; Snehaa K; Bhattacharya SN; Seyedmousavi S; van Diepeningen AD
    Mycopathologia; 2016 Aug; 181(7-8):497-504. PubMed ID: 27138574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium.
    Spader TB; Venturini TP; Rossato L; Denardi LB; Cavalheiro PB; Botton SA; Santurio JM; Alves SH
    Rev Iberoam Micol; 2013; 30(3):200-4. PubMed ID: 23402831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of virulence factors and antifungal susceptibilities of Fusarium strains isolated from keratitis cases].
    Çuhadar T; Karabıçak N; Özdil T; Özgür D; Otağ F; Hızel K; Kalkancı A
    Mikrobiyol Bul; 2018 Jul; 52(3):247-258. PubMed ID: 30156511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusarium Keratitis From a Comprehensive Eye Health Care Facility in South India: Molecular Characterization by MALDI-TOF Versus Polymerase Chain Reaction Sequencing, Species Complex Distribution, and Clinical Correlation.
    Bagga B; Das S; Tawde Y; Singh S; Shaw T; Sharma S; Ghosh A
    Cornea; 2023 Sep; 42(9):1150-1162. PubMed ID: 37267470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains.
    Pujol I; Guarro J; Gené J; Sala J
    J Antimicrob Chemother; 1997 Feb; 39(2):163-7. PubMed ID: 9069536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
    Arastehfar A; Daneshnia F; Salehi MR; Zarrinfar H; Khodavaisy S; Haas PJ; Roudbary M; Najafzadeh MJ; Zomorodian K; Charsizadeh A; Brouwer C; Pan W; Hagen F; Boekhout T
    J Med Microbiol; 2019 May; 68(5):770-777. PubMed ID: 30924763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes.
    Badali H; Cañete-Gibas C; Patterson H; Sanders C; Mermella B; Garcia V; Mele J; Fan H; Wiederhold NP
    Mycoses; 2021 Jul; 64(7):748-752. PubMed ID: 33755988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.
    Al-Hatmi AM; van Diepeningen AD; Curfs-Breuker I; de Hoog GS; Meis JF
    J Antimicrob Chemother; 2015 Apr; 70(4):1068-71. PubMed ID: 25538167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
    Arikan S; Lozano-Chiu M; Paetznick V; Nangia S; Rex JH
    J Clin Microbiol; 1999 Dec; 37(12):3946-51. PubMed ID: 10565912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.